| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Cost-effectiveness Analysis for Apixaban in the Acute Treatment and Prevention of Venous Thromboembolism in the Netherlands
|
de Jong, Lisa A.
|
|
2017
|
39 |
2 |
p. 288-302.e4
3.019713E6 p.
|
artikel
|
| 2 |
Developing New Medicines for Pediatric Oncology: Assessing Needs and Overcoming Challenges
|
Kaitin, Kenneth I.
|
|
2017
|
39 |
2 |
p. 236-237
2 p.
|
artikel
|
| 3 |
Do the European Medicines Agency Decisions Hurt Pediatric Melanoma Patients?
|
Rose, Klaus
|
|
2017
|
39 |
2 |
p. 253-265
13 p.
|
artikel
|
| 4 |
Editorial Board
|
|
|
2017
|
39 |
2 |
p. A2-
1 p.
|
artikel
|
| 5 |
Factors Affecting Gastrointestinal Absorption of Levothyroxine: A Review
|
Skelin, Marko
|
|
2017
|
39 |
2 |
p. 378-403
26 p.
|
artikel
|
| 6 |
Factors Associated with the Use of Hyaluronic Acid and Corticosteroid Injections among Patients with Radiographically Confirmed Knee Osteoarthritis: A Retrospective Data Analysis
|
Lapane, Kate L.
|
|
2017
|
39 |
2 |
p. 347-358
12 p.
|
artikel
|
| 7 |
Fluid Therapy Management in Hospitalized Patients: Results From a Cross-sectional Study
|
Brugnolli, Anna
|
|
2017
|
39 |
2 |
p. 311-321
11 p.
|
artikel
|
| 8 |
Impact of Paradoxical Decrease in High-density Lipoprotein Cholesterol Levels After Statin Therapy on Major Adverse Cardiovascular Events in Patients with Stable Angina Pectoris
|
Hirayama, Kenshi
|
|
2017
|
39 |
2 |
p. 279-287
9 p.
|
artikel
|
| 9 |
Informed Consent and Assent in Pediatric Oncology Trials
|
Shader, Richard I.
|
|
2017
|
39 |
2 |
p. 231-234
4 p.
|
artikel
|
| 10 |
Limitations of the Current Standards of Care for Treating Gout and Crystal Deposition in the Primary Care Setting: A Review
|
Keenan, Robert T.
|
|
2017
|
39 |
2 |
p. 430-441
12 p.
|
artikel
|
| 11 |
Management of Venetoclax-Posaconazole Interaction in Acute Myeloid Leukemia Patients: Evaluation of Dose Adjustments
|
Agarwal, Suresh K.
|
|
2017
|
39 |
2 |
p. 359-367
9 p.
|
artikel
|
| 12 |
Masthead
|
|
|
2017
|
39 |
2 |
p. A3-
1 p.
|
artikel
|
| 13 |
Monthly Oral Ibandronate Reduces Bone Loss in Korean Women With Rheumatoid Arthritis and Osteopenia Receiving Long-term Glucocorticoids: A 48-week Double-blinded Randomized Placebo-controlled Investigator-initiated Trial
|
Shin, Kichul
|
|
2017
|
39 |
2 |
p. 268-278.e2
27533 p.
|
artikel
|
| 14 |
More Efficient Compliance with European Medicines Agency and Food and Drug Administration Regulations for Pediatric Oncology Drug Development: Problems and Solutions
|
Milne, Christopher-Paul
|
|
2017
|
39 |
2 |
p. 238-245
8 p.
|
artikel
|
| 15 |
New Drugs for Rare Diseases in Children
|
Rose, Klaus
|
|
2017
|
39 |
2 |
p. 246-252
7 p.
|
artikel
|
| 16 |
Patient-centered Outcomes with Concomitant Use of Proton Pump Inhibitors and Other Drugs
|
Shamliyan, Tatyana A.
|
|
2017
|
39 |
2 |
p. 404-427.e36
4.27E38 p.
|
artikel
|
| 17 |
Phosphodiesterase Type 5 Inhibitors for the Treatment of Erectile Dysfunction: Pharmacology and Clinical Impact of the Sildenafil Citrate Orodispersible Tablet Formulation
|
Scaglione, Francesco
|
|
2017
|
39 |
2 |
p. 370-377
8 p.
|
artikel
|
| 18 |
Safety, Tolerability, and Sensorimotor Effects of Extended-release Dalfampridine in Adults With Cerebral Palsy: A Pilot Study
|
Bethoux, Francois
|
|
2017
|
39 |
2 |
p. 337-346
10 p.
|
artikel
|
| 19 |
Table of Contents
|
|
|
2017
|
39 |
2 |
p. A4-A5
nvt p.
|
artikel
|
| 20 |
Target Intestinal Microbiota to Alleviate Disease Progression in Amyotrophic Lateral Sclerosis
|
Zhang, Yong-guo
|
|
2017
|
39 |
2 |
p. 322-336
15 p.
|
artikel
|
| 21 |
Tocilizumab Promotes Regulatory T-cell Alleviation in STAT3 Gain-of-function−associated Multi-organ Autoimmune Syndrome
|
Khoury, Tawfik
|
|
2017
|
39 |
2 |
p. 444-449
6 p.
|
artikel
|
| 22 |
Using Health Care Claims Data to Assess the Prevalence of Hodgkin Lymphoma and Relapsed or Refractory Hodgkin Lymphoma in the United States
|
Lin, Jay
|
|
2017
|
39 |
2 |
p. 303-310
8 p.
|
artikel
|
Tijdschrift beschrijving